Nasdaq

Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for ...

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced final results from the HD ...
Nasdaq

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023 | Nasdaq

TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced 12 presentations across its ...
technologynetworks

Solutions for AAV Research & Development: AAV Titration and Anti-AAV Antibody ELISA Kits

Adeno-associated virus (AAV) vectors have emerged as a pivotal tool in gene therapy, offering a promising delivery system in treating genetic disorders. As AAV vector applications in gene therapy ...
GEN

AAV Titration Kit

The Gyrolab ® AAV9 Titer Kit was designed to allow researchers to improve productivity. The kit is based on an AAV9 affinity ligand developed with the Thermo Scientific™ CaptureSelect™ technology by ...
PharmiWeb

Teva Presents Real-World Data for AUSTEDO® (deutetrabenazine) Tablets with 4-Week Patient Titration Kit at Psych Congress Elevate 2023

START study provides real-world data for AUSTEDO with the use of a 4-week patient titration kit for adults with tardive dyskinesia (TD), including utilization and patient satisfaction AUSTEDO is the ...